Skip to main content
Drug bottle and Pill

Compare Triumeq vs. Baraclude

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Abacavir/dolutegravir/lamivudine (Triumeq) and entecavir (Baraclude) are both antiviral medications, but they treat different conditions. Triumeq is a combination medication used to treat HIV infections, while Baraclude is used for hepatitis B virus (HBV) infections. Both medications include nucleoside reverse transcriptase inhibitors (NRTIs) as part of their mechanism of action, but Triumeq also contains an integrase inhibitor. Triumeq is available as a tablet and a dissolvable tablet for oral suspension, whereas Baraclude is available as a tablet and a liquid solution. Triumeq is taken once daily and is not recommended for people with severe liver problems, while Baraclude must be taken on an empty stomach and requires dose adjustments for those with kidney issues. Triumeq requires genetic testing before use due to the risk of severe allergic reactions, and it can interact with many medications. Baraclude, on the other hand, is generally well-tolerated but is not recommended for people with both HBV and untreated HIV. Common side effects of Triumeq include headache and trouble sleeping, while Baraclude may cause headache and fatigue.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.